What can we help you find?

Leading the way in transplantation

Filter results for:

Calling transplant centres to share their experiences of COVID-19 vaccination practices

Building on the success of recent multi-society collaboration
This initiative builds on the recent success of our multi-society effort: a publication of the findings of a survey we held in 2020 and sent to 470 centres worldwide, serving to explore how patients, healthcare professionals, and liver transplant centres across the world were affected by the first wave of the COVID-19 pandemic.

A Reaffirmation of Organ Donation

International Medical Societies representing Transplantation Professionals across the globe support and nurture diversity and inclusion among their members, fostering education, and stand against any form of barriers in access, knowledge, transition and required training around the “Gift of Life”, particularly that related to gender, race, religion and income. We embrace a call of action to

ELITA Position statement and recommendations

2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation Authors: Christophe Duvoux, Luca S. Belli, James Fung, Mario Angelico, Maria Buti, Audrey Coilly, Paolo Cortesi, François Durand, Cyrille Féray, Constantino Fondevila, Pascal Lebray, Silvia Martini, Frederik Nevens, Wojciech G. Polak, Mario Rizzetto, Riccardo Volpes, Fabien Zoulim, Didier Samuel, Marina Berenguer   First published: 19 July 2021 – https://doi.org/10.1111/apt.16374

ELITA Call for Nominations

We would like to announce a call for nominations for one new Board member. All ESOT/ELITA affiliates are welcome to send nominations for this position. You may nominate yourself or a colleague. The new ELITA Board Member will hold office for 4 years (2021-2025). Considering the current composition of the Board and with the objective

ESOT multi-organ registry

On March 5th 2021, ESOT opened a tender for a technical provider that will build the multi-organ registry. ESOT is seeking the support of additional European national authorities and expect to finalise agreement with participating countries by the end of April 2021. In addition, ESOT is establishing contacts with non-European countries and registries. read more

The COVID-19 Vaccine Studies

Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader